Plasmapheresis Efficiency in Coronavirus Disease 2019: More Related to What You Add and Not What You Take Away?

Crit Care Med

Medical Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Saint Anne Hospital, Paris, France.

Published: June 2021

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000004926DOI Listing

Publication Analysis

Top Keywords

plasmapheresis efficiency
4
efficiency coronavirus
4
coronavirus disease
4
disease 2019
4
2019 add
4
add away?
4
plasmapheresis
1
coronavirus
1
disease
1
0
1

Similar Publications

Objectives: This study aimed to measure the psychometrics qualities of an extended model of the Theory of Planned Behavior (TPB) applied to plasma donation, and its relevance in the evaluation of interventions aiming at converting whole-blood donors (WBD) to plasma donation.

Methods: Two studies were conducted. The first (N= 433) compared the efficacy of two communication strategies (standard strategy centered on motivations to donate vs.

View Article and Find Full Text PDF

Background: Guillain-Barre Syndrome (GBS) is a severe autoimmune neuropathy that has to be treated quickly and efficiently in emergency situations, when both cost and effectiveness are vital.

Objective: To compare the clinical outcomes and cost-effectiveness of plasmapheresis and intravenous immunoglobulin (IVIG) in managing acute GBS in emergency departments.

Methodology: A prospective observational study conducted from January to December 2023 evaluated the treatment of adults with acute GBS using IVIG or plasmapheresis.

View Article and Find Full Text PDF

Background: Early in the COVID-19 pandemic, convalescent plasma (CP) emerged as a potentially effective treatment neutralising SARS-CoV-2. Early CP therapy with high neutralising antibody (NAb) titre may benefit COVID-19 outpatients and, in sufficient quantities even some hospitalised patients. This study details the process of setting up a CP bank, containing high- and low-titre CP for a clinical trial.

View Article and Find Full Text PDF

Therapeutic Apheresis in Pediatric Renal Transplant Recipients.

Exp Clin Transplant

October 2024

From the Urology and Nephrology Research Center, Shahidbeheshti of Medical Sciences, Tehran, Iran.

Clear guidelines for therapeutic apheresis in children after renal transplant do not exist. This article reviews the current experiences with therapeutic apheresis in pediatric transplant recipients. The ideal characteristics of removable substances should have all of the following criteria for an effective therapeutic apheresis: large molecular weight (>15 kDa), prolonged half-life, rapid elimination from the plasma, high intravascular distribution, and low turnover rate.

View Article and Find Full Text PDF

Comparison of efficacy and safety of different anticoagulation regimens in plasma exchange: A systematic review and meta-analysis.

PLoS One

October 2024

Department of Nephrology and Institute of Nephrology, Sichuan Clinical Research Centre for Kidney Diseases, School of Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

Article Synopsis
  • - The study investigates the effectiveness and safety of various anticoagulation methods used during plasma exchange (PE), noting that current methods can lead to clotting issues that waste nursing resources.
  • - A systematic review included 7 studies involving over 1,600 patients, finding that unfractionated heparin (UFH) was better than saline for preventing clotting but showed similar results to low-molecular-weight heparin (LMWH) and regional citrate anticoagulation (RCA).
  • - The findings suggest that while current anticoagulation methods are generally effective, there's a risk of longer post-treatment aPTT (a clotting test) and lower platelet counts with UFH; however, more research is needed for
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!